Page 3 - Management of Advanced Urothelial Carcinoma: Emerging Therapies and Biomarkers
P. 3

Presenter Disclosure











              Scott North

                                                                                Company / Organization                      Details

           I am a member of an Advisory Board or equivalent with a       Astellas                               National Advisory Board
           commercial organization
           I have received a grant(s) or an honorarium from a commercial   Astellas, Sanofi, Janssen, Novartis, Merck,   Honoraria
           organization or non-commercial organization                   Roche, CUA
           I am currently participating in or have participated in a clinical trial   Roche, Merck, Astellas    All funds paid to AHS
           within the past two year
   1   2   3   4   5   6   7   8